Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries.

Author: FernandezRafle, GjergjindreajMedeona, LozierMatthew, SendilSelin

Paper Details 
Original Abstract of the Article :
Obesity is a well-established cardiovascular (CV) risk factor with greater mortality and morbidity rates than the general population. Phentermine is a weight loss medication that is approved for short-term obesity treatment in conjunction with lifestyle modifications to decrease CV risk. A 51-year-o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805544/

データ提供:米国国立医学図書館(NLM)

Phentermine: A Potential Cardiovascular Risk Factor

Obesity is a known cardiovascular (CV) risk factor, and medications used for weight loss can sometimes have unexpected effects on the heart. This case report describes a 51-year-old female who experienced palpitations and worsening ST segment depressions following a regadenoson stress test after starting phentermine, a weight-loss medication. Although phentermine is generally considered safe for short-term obesity treatment, this case highlights the potential for CV complications, emphasizing the need for careful monitoring and evaluation in patients taking this medication.

Phentermine and Cardiovascular Health: A Complex Relationship

This case report underscores the importance of considering individual factors when prescribing phentermine for weight loss. While phentermine may be safe for many patients, it is crucial to be aware of the potential for CV complications and to monitor patients closely during treatment. Further research is needed to fully understand the CV risks and benefits associated with phentermine use.

Navigating Weight Loss Medications: Safety and Monitoring

Individuals considering weight-loss medications should discuss potential risks and benefits with their healthcare providers. It is crucial to provide a detailed medical history, including any existing medical conditions and medications taken, to ensure that weight-loss medications are safe and appropriate. Regular monitoring and follow-up appointments are essential for identifying any potential adverse effects and adjusting treatment plans accordingly.

Dr.Camel's Conclusion

Just as a camel's journey through the desert requires careful planning and attention to potential hazards, weight loss therapy involves a delicate balance of benefits and risks. This case report serves as a reminder of the importance of individualized care, careful monitoring, and a thorough understanding of the potential effects of weight-loss medications on cardiovascular health. By working closely with healthcare professionals, individuals can embark on a safe and successful weight loss journey.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-01-11
Further Info :

Pubmed ID

36601192

DOI: Digital Object Identifier

PMC9805544

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.